Proliferating Cell Nuclear Antigen Immunostaining in Breast Carcinoma and its Relationship to Clinical and Pathological Variables

Indian Journal of Pathology and Microbiology

Volumn 40, Issue 1, 1997, Pages 11-16

  Agarwal, Sarla ^a,b   Jain, Renu ^a   Rusia, Usha ^a   Gupta, R L ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^b UCMS AND GTB HOSPITAL   (India)

Author keywords

Breast; Carcinoma; PCNA; Proliferative activity

Indexed keywords

CYCLINE;

ARTICLE; BREAST TUMOR; CARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LYMPH NODE METASTASIS; MITOSIS INDEX;

BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MITOTIC INDEX; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 0030628036     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bravo R, Franke R, Blundell PA et al: Cyclin/PCNA is the auxiliary protein of DNA polymerase. Nature 326: 515-517, 1987.
2. Celis JE and Celis A: Cell cycle dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells. Subdivision of S phase. Proc Nat Acad Sci, USA, 82: 3262-3266, 1985.
3. Garcia RL, Coltrera MD, Gown AM: Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol, 134: 73-739, 1989.
4. Galand P, Degraef C: PCNA immunostaining as an alternative to Tritiated thymidine pulse lebelling for making S phase cells in paraffin sections from animal and human tissues. Cell tissue kinet, 22: 383-392, 1989.
5. Hall PA, Richards MA, Gregory WM. The prognostic significance of Ki67 immunostaining in non-Hodgkin lymphomas. J Pathol 154: 223-235, 1988.
6. Robbins BA de a, Vega D, Ogata K: Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Arch Pathol Lab Med, 111: 841-845, 1987.
7. WHO, The histological typing of breast tumours 2nd Ed. Amer J Clin Pathol, 78: 806-816, 1982.
8. Elston CW, Elus LO: Pathological prognostic factors in breast cancers I. The value of histological grade in breast cancer: Experience from a large study with a long term follow up. Histopathology, 19: 403-410, 1991.
9. Heyderman E: Immunoperoxidase technique in histopathology: Applications, methods and controls. J Clin Pathol, 32: 971, 1979.
10. Marija J: SPSS/PCT Basic system Vses's Guide version 5.0 Norusis/spss Inc. pg 287-360, 1992.
11. Miyachi K, Fritsler MJ, Tan EM: Autoantibodies to nuclear antigen in proliferating cells. J Immunol, 121: 2228-2234, 1978.
12. Smetana K, Gyorkey F, Chan PK. Proliferating cell nuclear antigen (PCNA) and human malignant tumour nucleolar antigens (HMTNA) in nucleoli of human haematological malignancies. Blood, 46: 133-141, 1983.
13. Gentilli C, Sanfilippo O, Silvestrini R: Cell proliferation and its relationship to clinical features and relapse in breast cancer. Cancer 48: 974-979, 1981.
14. Wrba F, Chott A, Reiner A: Ki67 immunoreactivity in breast carcinomas in relation to transferrm receptor expression, estrogen receptor status and morphological criteria. An immunohis- tochemical study. Oncology 46: 255-259, 1989.
15. Veronese SD, Gambacosta M: Detection of Ki67 proliferation rate in breast cancer. Correlation with clinical and pathological features. Am J Clin Pathol, 95: 30-34, 1991.
16. Wrba F, Rilzinger E, Reiner A: Transferrin receptor (TrfR) expression in breast carcinoma and its possible rela- tionship to prognosis. An immunohistochemical study. Virchows Arc A Pathol Anat, 410: 69-73, 1986.
17. Isola JJ, Helin HJ, Helle MJ et al: Evaluation of cell proliferation in breast carcinoma. Comparison of Ki67 immunohistochemical study. DNA flow cytometric analysis and mitotic count. Cancer, 65: 1180-1184, 1990.